FR2355293A2 - Procede de determination du degre d'insaturation d'un support d'un compose biologiquement actif dans un fluide biologique - Google Patents

Procede de determination du degre d'insaturation d'un support d'un compose biologiquement actif dans un fluide biologique

Info

Publication number
FR2355293A2
FR2355293A2 FR7718670A FR7718670A FR2355293A2 FR 2355293 A2 FR2355293 A2 FR 2355293A2 FR 7718670 A FR7718670 A FR 7718670A FR 7718670 A FR7718670 A FR 7718670A FR 2355293 A2 FR2355293 A2 FR 2355293A2
Authority
FR
France
Prior art keywords
unsaturation
carrier
determining
degree
active compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
FR7718670A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Instrument Inc
Original Assignee
SmithKline Instrument Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Instrument Inc filed Critical SmithKline Instrument Inc
Publication of FR2355293A2 publication Critical patent/FR2355293A2/fr
Pending legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/78Thyroid gland hormones, e.g. T3, T4, TBH, TBG or their receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/544Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
    • G01N33/545Synthetic resin
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/82Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving vitamins or their receptors
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/807Apparatus included in process claim, e.g. physical support structures
    • Y10S436/808Automated or kit
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/807Apparatus included in process claim, e.g. physical support structures
    • Y10S436/81Tube, bottle, or dipstick

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Endocrinology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

L'invention concerne un procédé de détermination du degré d'insaturation d'un support d'un composé biologiquement actif dans un fluide biologique, pour mesurer par exemple la capacité de fixation insaturée d'une globuline et d'autres protéines fixant des hormones, en incubant une quantité de substance biologique radioactivement marquée ajoutée à un échantillon du fluide biologique tamponné dans un tube à essai en plastique sur la paroi duquel on a appliqué du glutaraldéhyde avec une protéine spécifique de la substance biologique, accouplée de façon covalente, puis en mesurant la quantité de substance biologique marquée fixée par la protéine spécifique sur la paroi du tube, ou la quantité de substance biologique marquée restée dans le liquide séparé.
FR7718670A 1976-06-17 1977-06-17 Procede de determination du degre d'insaturation d'un support d'un compose biologiquement actif dans un fluide biologique Pending FR2355293A2 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/696,959 US4225784A (en) 1976-06-17 1976-06-17 Covalently bound biological substances to plastic materials and use in radioassay

Publications (1)

Publication Number Publication Date
FR2355293A2 true FR2355293A2 (fr) 1978-01-13

Family

ID=24799205

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7718670A Pending FR2355293A2 (fr) 1976-06-17 1977-06-17 Procede de determination du degre d'insaturation d'un support d'un compose biologiquement actif dans un fluide biologique

Country Status (4)

Country Link
US (1) US4225784A (fr)
JP (1) JPS52156696A (fr)
DE (1) DE2727206A1 (fr)
FR (1) FR2355293A2 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2436396A1 (fr) * 1978-09-12 1980-04-11 Baxter Travenol Lab Procede d'analyse pour determiner directement la concentration d'un composant libre dans un echantillon
EP0171871A1 (fr) * 1984-05-29 1986-02-19 Warner-Lambert Company Procédé pour déterminer la capacité de fixation insaturée d'une protéine de sérum

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4451571A (en) * 1981-04-06 1984-05-29 University Patents, Inc. Preparation of samples for vitamin B12 and/or folate assay and assay
US4434150A (en) 1981-10-19 1984-02-28 Ortho Diagnostic Systems, Inc. Immunological reagents employing polymeric backbone possessing reactive functional groups
US4604348A (en) * 1981-11-19 1986-08-05 New York Blood Center, Inc. Composition for use in immunoassays
US4477578A (en) * 1982-03-04 1984-10-16 Medical & Scientific, Inc. Method and apparatus for performing assays
US4652639A (en) * 1982-05-06 1987-03-24 Amgen Manufacture and expression of structural genes
US6936694B1 (en) * 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes
DE3311889A1 (de) * 1983-03-31 1984-10-11 Byk-Mallinckrodt Chemische Produkte Gmbh, 6057 Dietzenbach Verfahren zur irreversiblen bindung von protein an polystyroloberflaechen unter erhaltung der biologischen aktivitaet, so erhaltene polystyroloberflaechen und ihre verwendung
US4623629A (en) 1983-10-31 1986-11-18 Daniel Kerschensteiner Solid-phase immunoassay support and method of use thereof
US6326136B1 (en) 1988-04-01 2001-12-04 Digene Corporation Macromolecular conjugate made using unsaturated aldehydes
US5053054A (en) * 1988-09-12 1991-10-01 Ortho Pharmaceutical Corporation Methods and reagents for staining intracellular components
US5354692A (en) * 1992-09-08 1994-10-11 Pacific Biotech, Inc. Analyte detection device including a hydrophobic barrier for improved fluid flow

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3414383A (en) * 1965-08-09 1968-12-03 Canadian Patents Dev Determination of thyroxine
SE326845B (fr) * 1966-10-21 1970-08-03 Pharmacia Ab
SE337223B (fr) * 1967-05-23 1971-08-02 Pharmacia Ab
CH564031A5 (fr) * 1968-03-29 1975-07-15 Anvar
US3646346A (en) * 1968-12-26 1972-02-29 Pharmacia Ab Antibody-coated tube system for radioimmunoassay
US3666854A (en) * 1969-07-30 1972-05-30 Nuclear Med Lab Test for thyroid hormone
GB1392181A (en) * 1971-04-16 1975-04-30 Rech Et Dapplications Soc Gen Fixation of nitrogenous materials
US3826619A (en) * 1971-12-21 1974-07-30 Abbott Lab Test apparatus for direct radioimmuno-assay for antigens and their antibodies
US3941876A (en) * 1973-04-25 1976-03-02 Gte New Ventures Corporation In vitro method for determining allergic hypersensitivity
US3949064A (en) * 1973-10-26 1976-04-06 Baxter Laboratories, Inc. Method of detecting antigens or antibodies
US3951748A (en) * 1974-11-11 1976-04-20 Medical Products, Inc. Sensitized matrix for detection of disease

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2436396A1 (fr) * 1978-09-12 1980-04-11 Baxter Travenol Lab Procede d'analyse pour determiner directement la concentration d'un composant libre dans un echantillon
EP0171871A1 (fr) * 1984-05-29 1986-02-19 Warner-Lambert Company Procédé pour déterminer la capacité de fixation insaturée d'une protéine de sérum

Also Published As

Publication number Publication date
JPS52156696A (en) 1977-12-27
DE2727206A1 (de) 1977-12-29
US4225784A (en) 1980-09-30

Similar Documents

Publication Publication Date Title
FR2355293A2 (fr) Procede de determination du degre d'insaturation d'un support d'un compose biologiquement actif dans un fluide biologique
DE3705686C2 (de) Verfahren zur Bestimmung von Antikörpern
FR2382696A1 (fr) Procede et reactif pour analyses mettant en oeuvre des reactions d'affinite biospecifique
LV10538A (lv) Imunologiski saistamas vielas noteiksanas panemiens biologiska skidruma un diagnostikas lidzeklis
DK164944C (da) Fremgangsmaade, indretning og analysesaet til bestemmelse af koncentrationer af flere analytter i en vaeske
FR2630827B1 (fr) Dispositif et procede pour la determination qualitative et quantitative rapide de la presence d'un ligand reactif dans un fluide
FR2422165A1 (fr) Procede et necessaire de dosage d'une substance immunologique par mesure de la lumiere fluorescente emise
ATE186599T1 (de) Verfahren für nicht-kompetitive bindungsassays
FR2436396A1 (fr) Procede d'analyse pour determiner directement la concentration d'un composant libre dans un echantillon
FR2366568A1 (fr) Procede pour la determination d'une substance immunologiquement active
ES2101802T3 (es) Ensayo para determinar los niveles de igf-i, igf-ii y gh libres en liquidos corporales.
ES481208A1 (es) Un metodo para detectar anticuerpos.
NO169979C (no) Fremgangsmaate og proevesett til bestemmelse av frie virksomme stoffer i biologiske vaesker
KR890702039A (ko) 1,25-디하이드록시 비타민 d의 분석 방법
FR2396975A1 (fr) Procede de dosage d'hormones ou de produits pharmaceutiques non lies
NO943759D0 (no) Fremgangsmåte for bestemmelse av mengden av en ligand i et biologisk fluid, samt et analysesett for utförelse av en slik fremgangsmåte
JPH05504617A (ja) 免疫検定診断用キット
FR2365800A1 (fr) Procede de determination d'un reactif d'une reaction immunologique
ATE29591T1 (de) Salzbrueckenfluessigkeit fuer die potentiometrische blutanalyse.
BE903810A (fr) Procede de diagnostic pour l'evaluation de parametres cliniques, et dispositif pour sa mise en oeuvre.
ATE146596T1 (de) Diagnostisches verfahren und reagenz für hiv
FR2383445A1 (fr) Procede de determination de la concentration des hormones libres dans les fluides biologiques
Stevens et al. Immunochemical and electrophoretic properties of oestrous rabbit uterine fluid proteins obtained by uterine ligation
FI68653C (fi) Metod foer bestaemning av tyroxin-bindningsindex i serum och testfoerpackning foer utfoerande av bestaemningen
FR2403097A1 (fr) Dispositif absorbant revetu de charbon de bois